• info@zirconmedtech.in
  • +91 84600 39019
News Photo

Trade Margin Rationalisation: How Pharmaceutical Distributors Can Evaluate Profitability Across Different Product Categories

What Is Trade Margin Rationalisation in Pharmaceutical Distribution?

Trade margin rationalisation is the process of reviewing and adjusting pharmaceutical product margins to improve profitability while maintaining commercially sustainable pricing and distribution arrangements.

It involves evaluating the relationship between procurement costs, selling prices, operational expenses, product demand and inventory risks.

For example, a distributor may earn a higher gross margin percentage on a specialised medicine than on a commonly prescribed generic product. However, the specialised medicine may require additional storage, regulatory handling or inventory financing.

The distributor should therefore compare both the gross margin and the actual contribution remaining after relevant costs.

Common Reasons to Review Pharmaceutical Trade Margins

  • Identify product categories with strong sales but limited profitability.
  • Compare purchasing and distribution costs across medicine categories.
  • Understand how discounts and promotional arrangements affect margins.
  • Evaluate inventory holding costs and expiry-related losses.
  • Review the profitability of different customer segments.
  • Support better purchasing, pricing and product portfolio decisions.

Why Should Pharmaceutical Distributors Evaluate Profitability Across Product Categories?

Pharmaceutical distributors often manage products with different commercial characteristics. A single margin target may not reflect the actual costs and risks associated with each category.

Generic medicines may operate in competitive markets where pricing pressure is significant. Specialised medicines may have different purchasing conditions, demand volumes and storage requirements.

A category-level profitability review helps distributors understand which products generate sustainable financial returns and which require closer commercial attention.

A Profitability Review Should Establish

  • Which pharmaceutical categories generate the highest gross profit.
  • How procurement costs differ across suppliers and products.
  • Which categories involve higher logistics and storage expenses.
  • Whether sales discounts reduce expected profitability.
  • How inventory turnover affects working capital.
  • Which products face greater expiry or obsolescence risks.
  • Where pricing or purchasing arrangements may need adjustment.

Identify the Pharmaceutical Product Categories in Your Portfolio

Begin by grouping pharmaceutical products into categories that reflect the distributor's actual commercial operations.

The categories should be sufficiently detailed to highlight meaningful differences in pricing, handling requirements and customer demand.

Product Categories to Consider

Product Category

Key Commercial Considerations

Generic medicines

Competitive pricing, purchasing volumes and inventory turnover

Branded generic medicines

Brand positioning, procurement pricing and customer demand

Oncology medicines

Product-specific demand, expiry exposure and handling requirements

Injectable medicines

Packaging, transport conditions and storage requirements

Chronic therapy medicines

Replenishment frequency, demand consistency and stock availability

Specialty pharmaceuticals

Product-specific logistics, regulatory obligations and financing costs

A distributor may need to divide these categories further by manufacturer, dosage form, therapeutic segment or destination market.

The objective is to compare products with similar commercial characteristics rather than combining unrelated items into one profitability calculation.

Calculate Gross Margin for Each Pharmaceutical Product Category

Gross margin is an initial measure of pharmaceutical distribution profitability.

It shows the percentage of sales revenue remaining after deducting the cost of goods sold.

Gross Margin (%) = [(Net Sales Revenue − Cost of Goods Sold) ÷ Net Sales Revenue] × 100

For consistent comparisons, net sales revenue should account for relevant discounts, returns and credits. The cost of goods sold should follow the distributor's accounting policy, including applicable directly attributable inventory costs.

Hypothetical Example of Category-Level Gross Margins

Product Category

Net Sales Revenue

Cost of Goods Sold

Gross Margin

Generic medicines

$100,000

$82,000

18%

Branded generics

$80,000

$62,400

22%

Oncology medicines

$60,000

$49,200

18%

Injectable medicines

$50,000

$41,000

18%

These figures are hypothetical and are provided only to demonstrate the calculation. They do not represent actual pharmaceutical industry margins.

Although branded generics show the highest gross margin percentage in this example, the distributor still needs to review logistics, financing and inventory costs before determining which category delivers the strongest overall contribution.

Evaluate the Full Cost of Pharmaceutical Distribution

Gross margin alone does not explain the total financial performance of a pharmaceutical product.

Distributors should identify additional expenses that are relevant to each product category and determine whether those costs are already included in the cost of goods sold.

Avoid counting the same expense twice when calculating profitability.

Costs to Review Across Product Categories

  • Procurement costs: Supplier prices, purchasing charges and applicable import expenses.
  • Transportation costs: International freight, domestic distribution and specialised delivery requirements.
  • Storage costs: Warehousing, temperature-controlled facilities and inventory handling.
  • Regulatory and compliance costs: Applicable product documentation, approvals and quality-related activities.
  • Inventory financing costs: Capital committed to stock before customer payment.
  • Expiry and damage losses: Inventory write-offs, product deterioration and unsaleable stock.
  • Customer servicing costs: Order processing, delivery frequency, credit administration and returns management.

Where costs are shared across several categories, distributors should apply a consistent allocation method and document the assumptions used.

Compare Gross Margin With Contribution Margin

Contribution margin provides another perspective on pharmaceutical product profitability.

It measures the revenue remaining after deducting the costs classified as variable for the analysis.

Contribution Margin = Net Sales Revenue − Variable Costs

The calculation should include the cost of goods sold and any additional variable distribution expenses that have not already been included.

Hypothetical Example of a Contribution Margin Review

Financial Measure

Generic Medicines

Injectable Medicines

Net sales revenue

$100,000

$100,000

Cost of goods sold

$82,000

$80,000

Gross profit

$18,000

$20,000

Additional variable distribution costs

$4,000

$8,000

Contribution margin

$14,000

$12,000

Contribution margin percentage

14%

12%

In this example, injectable medicines have a higher gross margin but a lower contribution margin because of additional variable distribution costs.

The comparison demonstrates why pharmaceutical distributors should not evaluate category profitability using selling prices and purchasing costs alone.

Review Inventory Turnover and Working Capital Requirements

Inventory turnover can influence the financial performance of pharmaceutical distribution businesses.

Products that remain in storage for extended periods may increase financing expenses and create additional exposure to expiry-related losses.

A product with a relatively modest margin may still contribute positively when demand is consistent and inventory moves efficiently.

Questions to Ask During an Inventory Review

  • How frequently does each product category sell?
  • How many days of inventory are normally held?
  • Which products require larger minimum order quantities?
  • How much working capital is committed to each category?
  • Are slow-moving products approaching their expiry dates?
  • Can purchasing quantities be adjusted to reflect actual demand?
  • How do supplier lead times affect replenishment planning?

Distributors can also calculate inventory turnover using the cost of goods sold divided by average inventory value, provided the values are measured consistently.

Assess the Impact of Discounts and Customer Pricing

Customer discounts can significantly affect pharmaceutical trade margins.

A distributor may negotiate attractive procurement prices but lose part of the expected margin through customer rebates, volume discounts, promotional allowances or extended payment terms.

Review pricing arrangements alongside the actual costs of serving each customer group.

Pricing Factors to Evaluate

  • Standard selling price and actual realised selling price.
  • Customer-specific discounts and rebates.
  • Minimum order quantities and order frequency.
  • Delivery and handling expenses.
  • Customer credit periods and financing costs.
  • Product returns and applicable credit notes.
  • Contractual pricing commitments.

For example, two customers purchasing the same medicine may generate different contribution margins if one requires frequent small deliveries and extended payment terms.

Evaluate Pharmaceutical Sourcing Costs and Supplier Terms

Supplier arrangements can influence the profitability of different medicine categories.

Distributors should compare more than the quoted product price when evaluating sourcing opportunities.

Order quantities, payment terms, lead times, packaging configurations and delivery arrangements may affect the total cost of procurement.

Supplier Information to Review

  • Product name, strength, dosage form and pack size.
  • Manufacturer and manufacturing site details.
  • Quoted price and applicable currency.
  • Minimum order quantity.
  • Payment terms and commercial conditions.
  • Expected production and delivery lead times.
  • Agreed remaining shelf life.
  • Applicable documentation and quality requirements.
  • Responsibilities for freight, insurance and import-related charges.

When reviewing sourcing options with Zircon Medtech, distributors can provide product-specific requirements and expected purchasing volumes to support discussions about available products and commercial terms.

Understand How Product Expiry Risk Affects Profitability

Expiry-related losses can reduce the profitability of pharmaceutical distribution categories.

Medicines with limited remaining shelf life, unpredictable demand or longer procurement cycles may create additional financial exposure.

A higher purchase volume may reduce the unit acquisition price, but it can also increase the amount of stock at risk if sales do not meet expectations.

Checks Before Placing a Purchase Order

  • Compare expected demand with the proposed order quantity.
  • Confirm the minimum remaining shelf life required.
  • Review the estimated arrival and receiving dates.
  • Identify existing inventory approaching expiry.
  • Assess whether the product requires special storage conditions.
  • Review supplier arrangements for shortages, damage or nonconforming goods.
  • Confirm whether partial shipments are commercially and operationally suitable.

Product quality and regulatory requirements must remain mandatory conditions of supply, regardless of the potential financial return.

Develop a Product Category Profitability Scorecard

A profitability scorecard allows distributors to review financial and operational performance using a consistent set of indicators.

The scorecard can be updated monthly or quarterly depending on sales volume, inventory movement and management reporting requirements.

Suggested Pharmaceutical Profitability Scorecard

Performance Indicator

What to Measure

Net sales revenue

Revenue after applicable discounts, returns and credits

Gross margin percentage

Gross profit relative to net sales

Contribution margin

Revenue remaining after relevant variable costs

Inventory turnover

Speed at which inventory is sold or used

Inventory holding period

Average time products remain in stock

Expiry-related losses

Value of stock written off due to expiry

Logistics cost

Transport and handling expenses by category

Customer payment period

Time taken to collect customer payments

Supplier lead time

Time required to replenish inventory

The scorecard should use consistent reporting periods and accounting assumptions so category comparisons remain meaningful.

Hypothetical Example of Trade Margin Rationalisation

An international pharmaceutical distributor manages three product categories: generic medicines, branded generics and injectable medicines.

During a quarterly review, the distributor finds that branded generics generate a relatively strong gross margin, while generic medicines account for a larger share of sales volume.

Injectable medicines also generate meaningful revenue but involve higher handling and distribution expenses.

Rather than applying the same margin adjustment to every product, the distributor reviews each category separately.

How the Distributor Evaluates Its Portfolio

Category

Review Finding

Possible Commercial Response

Generic medicines

High sales volume with competitive pricing pressure

Review purchasing quantities and supplier pricing

Branded generics

Strong gross margin with moderate inventory turnover

Compare customer demand with replenishment schedules

Injectable medicines

Higher handling expenses reduce contribution margin

Review logistics arrangements and cost allocation

The distributor then compares the expected financial benefit of each proposed change with its operational and contractual implications.

This approach supports more informed pricing and procurement decisions without assuming that the category with the highest gross margin is automatically the most profitable.

Common Mistakes to Avoid in Pharmaceutical Trade Margin Rationalisation

Comparing Product Categories Using Gross Margin Alone

Include relevant logistics, financing, inventory and customer servicing expenses before evaluating category-level contribution.

Ignoring Slow-Moving Pharmaceutical Inventory

Review inventory turnover, demand forecasts and expiry exposure when assessing profitability.

Applying the Same Margin Target to Every Product

Consider the different commercial and operational characteristics of each medicine category.

Overlooking Customer Discounts and Credit Terms

Calculate profitability using actual realised revenue and relevant financing expenses rather than relying only on standard price lists.

Selecting Suppliers Based Only on Purchase Price

Evaluate supplier reliability, product quality, documentation, lead times and total procurement costs.

Reducing Costs Without Reviewing Compliance Requirements

Do not compromise required storage conditions, product quality, traceability or regulatory obligations to improve reported margins.

Discuss Your Pharmaceutical Sourcing Requirements With Zircon Medtech

Pharmaceutical distributors evaluating profitability across product categories can begin by reviewing their sourcing requirements, purchasing volumes and commercial objectives.

When contacting Zircon Medtech, provide the destination market, required pharmaceutical categories, exact product presentations, expected order quantities and preferred delivery schedules.

Include applicable documentation requirements, storage conditions and minimum remaining shelf-life expectations.

Clear sourcing information can help distributors assess available supply options and compare relevant commercial arrangements as part of a broader profitability review.

Visit Zircon Medtech

Zircon Medtech

Keeping Pharmaceutical Trade Margin Rationalisation Focused

Trade margin rationalisation should be an ongoing process rather than a one-time pricing exercise.

Begin with product categories that account for significant sales, inventory investment or operational expenses. Compare gross margins, contribution margins, inventory turnover and sourcing costs using consistent financial measures.

Review the findings whenever supplier terms, customer pricing, product demand or distribution expenses change.

A structured approach helps pharmaceutical distributors identify opportunities to improve commercial performance while maintaining the quality, compliance and supply reliability required in international pharmaceutical distribution.

Share This News

Comment

Do you want to get our quality service for your business?